References
- Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions – Introduction and key changes from the 1999 classification. Journal of Clinical Periodontology. 2018;89:1-8.
- Chapple ILC, Mealey BL, Van Dyke TE, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018;45:S68-S77.
- Zhang R, Wu J, Zhu J, Wang X, Song J. Bibliometric analysis of research trends and characteristics of drug-induced gingival overgrowth. Front Public Health. 2022;10:979861.
- Hughes FJ, Bartold PM. Periodontal complications of prescription and recreational drugs. Periodontol 2000. 2018;78:47-58.
- Tungare S, Paranjpe AG. Drug Induced Gingival Overgrowth. 2022 Sep 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
- Chacko LN, Abraham S. Phenytoin-induced gingival enlargement. BMJ Case Rep. 2014;2014:bcr2014204670.
- Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement. J Hum Hypertens. 2014;28:10-14.
- Quenela L, Keribinb P, Giranc G, Tessierd MH, Lesclouse P. Amlodipine-induced gingival enlargement: A case report. Journal of Stomatology, Oral and Maxillofacial Surgery. 2020;121:308-311.
- Haruna H, Junko A, Yuuki H, et al. Drug-induced gingival hyperplasia: a retrospective study using spontaneous reporting system databases. Journal of Pharmaceutical Health Care and Sciences. 2017;3:19-25.
- Syed AR, Omar BK, Bassel T, Dilshad U, Salah I. Propranolol-induced gingival hyperplasia with Nager syndrome: A rare adverse drug reaction. Journal of Advanced Pharmaceutical Technology and Research. 2016;7:64-68.
- Chojnacka-Purpurowicz J, Wygonowska E, Placek W, Owczarczyk-Saczonek A. Cyclosporine-induced gingival overgrowth – Review. Dermatol Ther. 2022;35:e15912.
- Claudio G, Giada B, Giuseppe Z, Carla MC. Gingival overgrowth induced by anticonvulsant drugs: A cross-sectional study on epileptic patients. Journal of Periodontal Research. 2020;57:363-369.
- Heasman PA, Hughes FJ. Drugs, medications and periodontal disease. Br Dent J. 2014;217:411-419.
- Markou E, Eleana B, Lazaros T, Antonios K. The influence of sex steroid hormones on gingiva of women. Open Dent J. 2009;3:114-119.
- Emmanuelle BG, Haleh B, Jean-Louis M. Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. Journal of Clinical Periodontology. 2012;39:513-518.
- Lauritano D, Lucchese A, Di Stasio D, et al. Molecular Aspects of Drug-Induced Gingival Overgrowth: An In Vitro Study on Amlodipine and Gingival Fibroblasts. Int J Mol Sci. 2019;20:2047.
- Bajkovec L, Mrzljak A, Likic R, Alajbeg I. Drug-induced gingival overgrowth in cardiovascular patients. World J Cardiol. 2021;13:68-75.
- Ustaoğlu G, Erdal E, Karaş Z. Influence of different anti-hypertensive drugs on gingival overgrowth: A cross-sectional study in a Turkish population. Oral Dis. 2021;27:1313-1319.
- Kamei H, Furui M, Matsubara T, Inagaki K. Gingival enlargement improvement following medication change from amlodipine to benidipine and periodontal therapy. BMJ Case Rep. 2022;15:e249879.
- Trackman PC, Kantarci A. Molecular and Clinical Aspects of Drug-induced Gingival Overgrowth. Journal of Dental Research. 2015;94:540-54.
- Debra F. Drug-Induced Gingival Overgrowth: More than a Cosmetic Issue. Pharmacy Times. 2015;81:7-14.